- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Waft Pharma covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (75), financial health (40), director (95) and company-foundation signals.
- Operating for 8 years.
- Company status is Active as per MCA.
- Last balance sheet filed for Mar 2022 - filings look overdue.
- Loss-making in FY 2019.
- Positive net worth.
- 5 directors on the board.
- No disqualified or deactivated DINs on the current board.
About Waft Pharma
Waft Pharma is an MCA-registered Indian company: a Private Limited Indian Non-Government Company (CIN U33100AP2017PTC106922). Business overview includes Pharma (Drug Formulation & Development), incorporated on October 26, 2017 (9+ years old), headquartered in Rajamahendravaram, Andhra Pradesh, India. The company is currently Active with Active Compliant compliance status.
- Location 74-2-5/1, 1St Floor, Opposite Niveditha Kishore Public School, Addepalli Colony, Ava Roa, Rajamahendravaram, Andhra Pradesh - 533103
- Website waftpharma.com
Financial Performance of Waft Pharma
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Waft Pharma (5)
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Hospital and Medical Care | - | 100 |
Flagged By Authority
Regulatory and exchange flags (preview)
Legal Cases of Waft Pharma
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
